My watch list
my.bionity.com  
Login  

Protease Inhibitors

News Protease Inhibitors

  • A new way to nip AIDS in the bud

    When new AIDS virus particles bud from an infected cell, an enzyme named protease activates to help the viruses mature and infect more cells. That's why modern AIDS drugs control the disease by inhibiting protease. Now, University of Utah researchers found a way to turn protease into a double-edged more

  • Advises on compassionate use of a new combination therapy for chronic hepatitis C

    The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given an opinion on the use of a fixed-dose combination of ledipasvir and sofosbuvir in the treatment of chronic (long-term) hepatitis C virus (HCV) infection in a compassionate-use programme. Compassionate-use more

  • European Medicines Agency advises on compassionate use of daclatasvir

    The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given an opinion on the use of daclatasvir in combination with sofosbuvir in the treatment of chronic (long-term) hepatitis C virus (HCV) infection, in a compassionate-use programme. Compassionate-use programme more

All news on protease inhibitors

White papers Protease Inhibitors

Publications Protease Inhibitors

All publications on protease inhibitors
Definition

Protease inhibitor pharmacology

Protease inhibitor pharmacology :For natural protease inhibitors, please see protease inhibitor (biology) Protease inhibitors (PIs) are a class of medication used to treat or prevent infection by virus es, including HIV and Hepatitis C . P ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE